Finance

Lists
ALM:BME
Almirall SA
10,36 €
+0,58%
(+0,060) 1D
23 қаз., 17:36:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALM...
Open
10,32 €
High
10,40 €
Low
10,16 €
Mkt. cap
2,25 млрд
Avg. vol.
123,87 м.
Volume
113,91 м.
Dividend
1,81%
Quarterly dividend
0,05 €
Ex-dividend date
2017 ж. 30 мам.
P/E ratio
38,39
52-wk high
13,98 €
52-wk low
9,81 €
EPS
0,27 €
Shares outstanding
217,78 млн
No. of employees
2 мың
Open
10,32 €
High
10,40 €
Low
10,16 €
Mkt. cap
2,25 млрд
Avg. vol.
123,87 м.
Volume
113,91 м.
Dividend
1,81%
Quarterly dividend
0,05 €
Ex-dividend date
2017 ж. 30 мам.
P/E ratio
38,39
52-wk high
13,98 €
52-wk low
9,81 €
EPS
0,27 €
Shares outstanding
217,78 млн
No. of employees
2 мың
News stories
From web sources and news partners
Northeast Mississippi Daily Journal
Northeast Mississippi Daily Journal
·
1 сағат бұрын
Wall Street closes lower to end rocky week
Profile
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology. With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
About Almirall SA
CEOCarlos Gallardo Piqué | Gianfranco Nazzi
Employees2,1 мың
Founded1943
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 24 шіл.
Fiscal period
Q2 2026
0,12 € / 0,13 €
-6,92%miss
Revenue / Est. (EUR)
605,62 млн / 312,50 млн
+93,80%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
262,23 млн
288,93 млн
292,40 млн
313,22 млн
Cost of goods sold
157,74 млн
-27,67 млн
104,30 млн
31,26 млн
Cost of revenue
157,74 млн
-27,67 млн
104,30 млн
31,26 млн
Research and development expenses
102,40 млн
-102,40 млн
34,80 млн
-34,80 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
234,95 млн
-102,92 млн
121,60 млн
14,88 млн
Operating expense
81,32 млн
310,92 млн
158,10 млн
240,19 млн
Total operating expenses
239,05 млн
283,25 млн
262,40 млн
271,44 млн
Operating income
23,18 млн
5,69 млн
30,00 млн
41,78 млн
Other non operating income
2,16 млн
3,36 млн
-1,70 млн
-2,27 млн
EBT including unusual items
20,97 млн
9,35 млн
23,40 млн
37,45 млн
EBT excluding unusual items
23,37 млн
5,78 млн
24,50 млн
36,46 млн
Income tax expense
8,45 млн
2,29 млн
8,10 млн
13,20 млн
Effective tax rate
40,30%
24,54%
34,62%
35,24%
Other operating expenses
-179,66 млн
365,05 млн
1,70 млн
184,83 млн
Net income
12,52 млн
7,05 млн
15,30 млн
24,25 млн
Net profit margin
4,77%
2,44%
5,23%
7,74%
Earnings per share
-
-
-
-
Interest and investment income
1,37 млн
1,35 млн
1,00 млн
1,54 млн
Interest expense
-3,89 млн
-5,05 млн
-4,50 млн
-4,62 млн
Net interest expenses
-2,52 млн
-3,70 млн
-3,50 млн
-3,08 млн
Depreciation and amortization charges
-76,38 млн
151,18 млн
-
75,28 млн
EBITDA
69,66 млн
23,70 млн
67,50 млн
69,12 млн
Gain or loss from assets sale
-
199,00 м.
-
114,00 м.
AI content may include mistakes. Learn more
Google қолданбалары